149 related articles for article (PubMed ID: 22333459)
41. Transcription-modulatory activities of differentially spliced cDNAs encoding the E2 protein of human papillomavirus type 16.
Alloul N; Sherman L
J Gen Virol; 1999 Sep; 80 ( Pt 9)():2461-2470. PubMed ID: 10501502
[TBL] [Abstract][Full Text] [Related]
42. The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.
Siddiqa A; Léon KC; James CD; Bhatti MF; Roberts S; Parish JL
J Gen Virol; 2015 Aug; 96(8):2274-2285. PubMed ID: 25911730
[TBL] [Abstract][Full Text] [Related]
43. Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein.
Sethi N; Palefsky J
Hum Gene Ther; 2003 Jan; 14(1):45-57. PubMed ID: 12573058
[TBL] [Abstract][Full Text] [Related]
44. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.
Demeret C; Desaintes C; Yaniv M; Thierry F
J Virol; 1997 Dec; 71(12):9343-9. PubMed ID: 9371593
[TBL] [Abstract][Full Text] [Related]
45. Functional interaction between human papillomavirus type 18 E2 and poly(ADP-ribose) polymerase 1.
Lee D; Kim JW; Kim K; Joe CO; Schreiber V; Ménissier-De Murcia J; Choe J
Oncogene; 2002 Aug; 21(38):5877-85. PubMed ID: 12185587
[TBL] [Abstract][Full Text] [Related]
46. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity.
Romanczuk H; Howley PM
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3159-63. PubMed ID: 1313584
[TBL] [Abstract][Full Text] [Related]
47. Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation.
Kumar RA; Naidu SR; Wang X; Imbalzano AN; Androphy EJ
J Virol; 2007 Mar; 81(5):2213-20. PubMed ID: 17151122
[TBL] [Abstract][Full Text] [Related]
48. Identification of single amino acids in the human papillomavirus 11 E2 protein critical for the transactivation or replication functions.
Cooper CS; Upmeyer SN; Winokur PL
Virology; 1998 Feb; 241(2):312-22. PubMed ID: 9499806
[TBL] [Abstract][Full Text] [Related]
49. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.
Kornuc M; Kliewer S; Garcia J; Harrich D; Li C; Gaynor R
J Virol; 1990 May; 64(5):2004-13. PubMed ID: 2139139
[TBL] [Abstract][Full Text] [Related]
50. Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6.
Ai W; Narahari J; Roman A
J Virol; 2000 Jun; 74(11):5198-205. PubMed ID: 10799595
[TBL] [Abstract][Full Text] [Related]
51. Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.
Newhouse CD; Silverstein SJ
J Virol; 2001 Feb; 75(4):1722-35. PubMed ID: 11160670
[TBL] [Abstract][Full Text] [Related]
52. The role of the globular heads of the C1q receptor in HPV-16 E2-induced human cervical squamous carcinoma cell apoptosis via a mitochondria-dependent pathway.
Chen ZL; Su YJ; Zhang HL; Gu PQ; Gao LJ
J Transl Med; 2014 Oct; 12():286. PubMed ID: 25288439
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the human p11 promoter sequence.
Huang X; Pawliczak R; Yao XL; Madara P; Alsaaty S; Shelhamer JH; Cowan MJ
Gene; 2003 May; 310():133-42. PubMed ID: 12801640
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction.
White PW; Titolo S; Brault K; Thauvette L; Pelletier A; Welchner E; Bourgon L; Doyon L; Ogilvie WW; Yoakim C; Cordingley MG; Archambault J
J Biol Chem; 2003 Jul; 278(29):26765-72. PubMed ID: 12730224
[TBL] [Abstract][Full Text] [Related]
55. Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.
Yan J; Li Q; Lievens S; Tavernier J; You J
J Virol; 2010 Jan; 84(1):76-87. PubMed ID: 19846528
[TBL] [Abstract][Full Text] [Related]
56. TAF1 interacts with and modulates human papillomavirus 16 E2-dependent transcriptional regulation.
Centeno F; Ramírez-Salazar E; García-Villa E; Gariglio P; Garrido E
Intervirology; 2008; 51(2):137-43. PubMed ID: 18580066
[TBL] [Abstract][Full Text] [Related]
57. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
58. A mutation study of the DNA binding domain of human papillomavirus type11 E2 protein.
Matsumoto T; Nakashima N; Takase K; Hirochika H; Mizuno H
J Biochem; 1997 Jan; 121(1):138-44. PubMed ID: 9058204
[TBL] [Abstract][Full Text] [Related]
59. Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro.
McBride AA; Klausner RD; Howley PM
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7531-5. PubMed ID: 1323841
[TBL] [Abstract][Full Text] [Related]
60. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.
Schmidt HM; Steger G; Pfister H
J Virol; 1997 Oct; 71(10):8029-34. PubMed ID: 9311900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
